CD24 genetic variants contribute to overall survival in patients with gastric cancer

Table 5 Results of multivariate Cox regression analysis

	P value	HR	95%CI
P-534
C/C + C/A	-	1.00	-
A/A	0.0416	1.38	1.01-1.88
Age	0.1875	1.01	1.00-1.02
Sex
Male	-	1.00	-
Female	0.2315	0.83	0.61-1.13
Differentiation
Moderate to well	-	1.00	-
Poor	0.0089	1.50	1.11-2.04
Pathologic type
Tubular adenocarcinoma	-	1.00	-
Signet ring cell	0.4750	0.83	0.50-1.39
Other	0.9469	1.01	0.67-1.53
TNM stage
I	-	1.00	-
II	0.0003	5.50	2.18-13.86
III	< 0.0001	22.29	9.05-54.89
IV	< 0.0001	32.12	12.63-81.70
Chemotherapy
No	-	1.00	-
FOLFOX-4	0.0195	0.64	0.45-0.93
XELOX	0.0021	0.43	0.25-0.74
Other	0.0004	0.45	0.29-0.70